LCO yields 7.91% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, LCO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LCO + PFE for your $10,000?
LCO is actively managed and seeks total return through capital appreciation and income. It invests in US and foreign equity securities, preferred stocks, fixed income instruments, US Treasurys, and shares of other investment companies, including ETFs. The fund uses a contrarian investment approach, betting that the market is wrong. It buys companies others do not want based on valuation. Equity selection considers valuation, earnings growth, cash flow, balance sheet strength, industry outlook, competitive positioning, management quality, and macroeconomic trends. Fixed-income selection factors include credit quality, yield relative to duration, issuer fundamentals, liquidity, interest rate sensitivity, and diversification. The portfolio typically holds 30 to 75 positions, with equity as the majority. Option strategies are also used to generate income, hedge risks, and reduce volatility. The portfolio is reviewed regularly for reallocation.
Full LCO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.